✦ LIBER ✦

Factors Influencing 5-year Overall Survival in Patients With the Ewing Sarcoma Family of Tumors

✍ Scribed by Denniston, K.; Lin, C.; Brown, C.K.; Zhen, W.; Enke, C.

Book ID: 123589582
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 69 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.1702

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors for overall survival

Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol

✍ José Luis López Guerra; Catalina Márquez-Vega; Gema Lucía Ramírez-Villar; Patric 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 388 KB

Factors influencing local recurrence and

Factors influencing local recurrence and survival in patients with soft tissue sarcoma of the upper limb

✍ J. W. Serpell; A. B. S. Ball; Mr J. M. Thomas; M. H. Robinson; I. Fryatt; C. Fis 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

Prognostic factors and clinical outcome

Prognostic factors and clinical outcome of patients with Ewing’s sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology

✍ Erkan Arpaci, Tarkan Yetisyigit, Metin Seker, Dogan Uncu, Ummugul Uyeturk, Berna 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 360 KB

Insulin-like growth factor type 1 (IGF–1

Insulin-like growth factor type 1 (IGF–1) and IGF binding protein–3 in patients with Ewing sarcoma family of tumors

✍ Jeffrey A. Toretsky; Seth M. Steinberg; Manjusha Thakar; Debra Counts; Baiba Pir 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 3 views

Clinical outcome of patients with Ewing

Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan : The Japanese Musculoskeletal Oncology Group cooperative study

✍ Hideto Obata; Takafumi Ueda; Akira Kawai; Takeshi Ishii; Toshifumi Ozaki; Satosh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Insulin Growth Factor-Receptor (IGF-1R)

Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors

✍ Naing, A.; LoRusso, P.; Fu, S.; Hong, D. S.; Anderson, P.; Benjamin, R. S.; Ludw 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 653 KB